Cancer Letters

Cancer Letters

Volume 90, Issue 1, 23 March 1995, Pages 43-50
Cancer Letters

Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer

https://doi.org/10.1016/0304-3835(94)03676-AGet rights and content

Abstract

In this paper we describe how research on the mouse mammary tumor virus model of breast cancer resulted in the identification of an amplified region of DNA on human chromosome 11 band q13. This amplification occurs in approximately 15% of primary breast cancers. Several candidate oncogenes map within the amplicon but by analysing expression of these genes a strong case can be made for a role for cyclin D1 in tumorigenesis. Immunohistochemical staining indicates that cyclin D1 is expressed at elevated levels in around 40% of breast cancers, including those with the 11q13 amplification. The potential function of cyclin D1 as a regulator of early cell division cycle events would be consistent with a role in neoplasia.

References (70)

  • E.M. Petty et al.

    A pulsed-field gel electrophoresis (PFGE) map of twelve loci on chromosome, 11q11–q13

    Genomics

    (1993)
  • P. Gaudray et al.

    DNA amplification at, 11q13 in human cancer: from complexity to perplexity

    Mutat. Res.

    (1992)
  • E.M.J.J. Berns et al.

    Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors

    Eur. J. Cancer

    (1992)
  • R. Callahan

    Genetic alterations in primary breast cancer

    Breast Cancer Res. Treat.

    (1989)
  • G. Peters

    Inappropriate expression of growth factor genes in tumors induced by mouse mammary tumor virus

  • H. Sakamoto et al.

    Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa

  • P. Delli Bovi et al.

    An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family

    Cell

    (1987)
  • J. Adelaide et al.

    Chromosomal localization of the hst oncogene and its co-amplification with the int.2 oncogene in a human melanoma

    Oncogene

    (1988)
  • M. Goldfarb et al.

    Cell transformation by Int-2 — a member of the fibroblast growth factor family

    Oncogene

    (1991)
  • P. Delli-Bovi et al.

    Processing, secretion and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential

    Mol. Cell. Biol.

    (1988)
  • F. Fuller-Pace et al.

    Cell transformation by kFGF requires secretion but not glycosylation

    J. Cell. Biol.

    (1991)
  • D. Talarico et al.

    The K-fgf/hst oncogene induces transformation through an autocrine mechanism that requires extracellular stimulation of the mitogenic pathway

    Mol. Cell. Biol.

    (1991)
  • W. Muller et al.

    The int-2 gene product acts as an epithelial growth factor in transgenic mice

    EMBO J.

    (1990)
  • D. Omitz et al.

    Int-2, an autocrine and/or ultra-short-range effector in transgenic mammary tissue transplants

    J. Natl. Cancer Inst.

    (1992)
  • G. Stamp et al.

    Nonuniform expression of a mouse mammary tumor virus-driven int-2/Fgf-3 transgene in pregnancy-responsive breast tumors

    Cell Growth Diff.

    (1992)
  • G. Casey et al.

    Characterization and chromosome assignment of the human homolog of int-2, a potential proto-oncogene

    Mol. Cell. Biol.

    (1986)
  • D.J. Zhou et al.

    Amplification of human int-2 in breast cancers and squamous carcinomas

    Oncogene

    (1988)
  • R. Lidereau et al.

    Amplification of the int-2 gene in primary human breast tumors

    Oncogene Res.

    (1988)
  • J.M. Varley et al.

    A common alteration to the int-2 protooncogene in DNA from primary breast carcinomas

    Oncogene

    (1988)
  • M.C. Yoshida et al.

    Human HST1 (HSTF1) gene maps to chromosome band, 11q13 and coamplifies with the INT2 gene in human cancer

  • T. Tsuda et al.

    High incidence of coamplification of hst-1 andint-2 genes in human esophageal carcinomas

    Cancer Res.

    (1989)
  • C. Theillot et al.

    Amplification ofFGF-related genes in human tumors: possible involvement of HST in breast carcinomas

    Oncogene

    (1989)
  • G. Peters et al.

    The mouse homolog of the hst/k-FGF gene is adjacent to int-2 and activated by proviral insertion in some virally induced mammary tumors

  • D.S. Liscia et al.

    Expression of int-2 mRNA in human tumors amplified at the int-2 locus

    Oncogene

    (1989)
  • E. Schuuring et al.

    Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome, 11q13 region in human carcinomas

    Oncogene

    (1992)

    • Cited by (161)

    • Biological, preclinical and clinical aspects of the association between radiation therapy and CDK4/6 inhibitors

      2023, Cancer/Radiotherapie

    • CDK4/6 inhibitors in the treatment of patients with breast cancer: Summary of a multidisciplinary round-table discussion

      2018, ESMO Open

    • E3 ligase MG53 suppresses tumor growth by degrading cyclin D1

      2023, Signal Transduction and Targeted Therapy

    • Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B

      2023, Clinical Cancer Research

    • Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation

      2023, Cell Death and Disease

    • Mechanism of CDK4/6 Inhibitor Resistance in Hormone Receptor-positive Breast Cancer and Alternative Treatment Strategies

      2023, Anticancer Research
    View all citing articles on Scopus
    View full text
    Copyright © 1995 Published by Elsevier Ireland Ltd.